As of 2026-10-17, the Relative Valuation of Karuna Therapeutics Inc (KRTX) is (304.08) USD. This relative valuation is based on P/E multiples. With the latest stock price at 329.83 USD, the upside of Karuna Therapeutics Inc based on Relative Valuation is -192.2%.
The range of the Relative Valuation is (252.36) - (306.93) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.2x - 27.0x | 26.7x |
| Forward P/E multiples | 20.2x - 27.0x | 26.8x |
| Fair Price | (252.36) - (306.93) | (304.08) |
| Upside | -176.5% - -193.1% | -192.2% |
| Date | P/E |